Michael E. Menefee
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 20
- Cancer Treatment and Pharmacology 8
- Cancer-related Molecular Pathways 4
-
- Thyroid Cancer Diagnosis and Treatment 11
- Co-authors
- Tito Fojo (3 shared papers)Antonio Tito Fojo (6 shared papers)Keith C. Bible (12 shared papers)Robert C. Smallridge (9 shared papers)Charles Erlichman (11 shared papers)Jill K. Burton (6 shared papers)William J. Maples (4 shared papers)Vera J. Suman (4 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (3 papers)Investigational New Drugs (3 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)
- Partner nations
- United StatesSingaporeCanada
In The Last Decade
Michael E. Menefee
42 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 78
- Endocrinology, Diabetes and Metabolism 560
- Oncology 610
- Cancer Research 181
- Cell Biology 123
- Molecular Biology 484
Countries citing papers authored by Michael E. Menefee
This map shows the geographic impact of Michael E. Menefee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Menefee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Menefee more than expected).
Fields of papers citing papers by Michael E. Menefee
This network shows the impact of papers produced by Michael E. Menefee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Menefee. The network helps show where Michael E. Menefee may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Menefee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 330 | |
| 2 | 2007 | 186 | |
| 3 | 2012 | 131 | |
| 4 | 2017 | 98 | |
| 5 | 2005 | 97 | |
| 6 | 2013 | 93 | |
| 7 | 2014 | 55 | |
| 8 | 2012 | 52 | |
| 9 | 2010 | 34 | |
| 10 | 2009 | 31 | |
| 11 | 2004 | 26 | |
| 12 | 2005 | 23 | |
| 13 | 2009 | 23 | |
| 14 | 2019 | 19 | |
| 15 | 2010 | 19 | |
| 16 | 2013 | 14 | |
| 17 | 2020 | 13 | |
| 18 | 2005 | 7 | |
| 19 | 2015 | 6 | |
| 20 | 2008 | 6 |
About Michael E. Menefee
Michael E. Menefee is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (11 papers), Cancer Treatment and Pharmacology (8 papers), Cancer, Hypoxia, and Metabolism (8 papers), BRCA gene mutations in cancer (5 papers), Microtubule and mitosis dynamics (4 papers), Cancer Genomics and Diagnostics (4 papers), Cancer-related Molecular Pathways (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (560 citations), Oncology (610 citations), Cancer Research (181 citations), Cell Biology (123 citations) and Molecular Biology (484 citations). Michael E. Menefee has collaborated with scholars based in United States, Singapore and Canada. Frequent co-authors include Tito Fojo, Antonio Tito Fojo, Keith C. Bible, Robert C. Smallridge, Charles Erlichman, Jill K. Burton, William J. Maples, Vera J. Suman, Julian R. Molina and Boon Cher Goh. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics, Clinical Cancer Research, Investigational New Drugs and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.